Gastroenterology and Hepatology - Prova Education

17-32 of 58

IBD Immunopathogenesis: Do You Know What You're Blocking?
IBD Immunopathogenesis: Do You Know What You're Blocking?
MinuteCE®
IBD Immunopathogenesis: Do You Know What You're Blocking?
Kimberly D. Orleck, PA-C; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- Kimberly D. Orleck, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Treat-to-Target: Are We There Yet? 
Treat-to-Target: Are We There Yet? 
MinuteCE®
Treat-to-Target: Are We There Yet? 
Kimberly D. Orleck, PA-C; Jennifer Geremia, PA-C
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
Case Review: Targets Are Met—Can You Stick the Landing? 
Case Review: Targets Are Met—Can You Stick the Landing? 
MinuteCE®
Case Review: Targets Are Met—Can You Stick the Landing? 
David Rubin, MD; Jennifer Geremia, PA-C
1.00 program credit
- David Rubin, MD
- Jennifer Geremia, PA-C
1.00 program credit
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
CME/CE
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
Naim Alkhouri, MD, FAASLD, DABOM
0.25 credits
- Naim Alkhouri, MD, FAASLD, DABOM
0.25 credits
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
0.25 credits
- Darren Brenner, MD
0.25 credits
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
0.25 credits
- Naim Alkhouri, MD, FAASLD, DABOM
0.25 credits
Advances in the Treatment and Management of MASH: More Options, More Decisions
Advances in the Treatment and Management of MASH: More Options, More Decisions
CME/CE Broadcast Replay
Advances in the Treatment and Management of MASH: More Options, More Decisions
Mary E. Rinella, MD, FAASLD; Naga Chalasani, MD, FAASLD
1.50 credits
- Mary E. Rinella, MD, FAASLD
- Naga Chalasani, MD, FAASLD
- Mazen Noureddin, MD, MHSc
1.50 credits
Primary Biliary Cholangitis Is Risky Business
Primary Biliary Cholangitis Is Risky Business
MinuteCE®
Primary Biliary Cholangitis Is Risky Business
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG; Atoosa Rabiee, MD
1.00 program credit
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
- Atoosa Rabiee, MD
1.00 program credit
Primary Biliary Cholangitis: The Phenotype, It Is a Changin'
Primary Biliary Cholangitis: The Phenotype, It Is a Changin'
MinuteCE®
Primary Biliary Cholangitis: The Phenotype, It Is a Changin'
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG; Atoosa Rabiee, MD
1.00 program credit
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
- Atoosa Rabiee, MD
1.00 program credit
Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis: Do You Know the Difference?
Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis: Do You Know the Difference?
MinuteCE®
Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis: Do You Know the Difference?
Marlyn Mayo, MD; Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
- Marlyn Mayo, MD
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
The Treatment Pipeline for Primary Biliary Cholangitis: IBAT Inhibition and Beyond
The Treatment Pipeline for Primary Biliary Cholangitis: IBAT Inhibition and Beyond
MinuteCE®
The Treatment Pipeline for Primary Biliary Cholangitis: IBAT Inhibition and Beyond
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG; Marlyn Mayo, MD
1.00 program credit
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
- Marlyn Mayo, MD
1.00 program credit
The Treatment Pipeline for Primary Biliary Cholangitis: Sorting Out the PPARs
The Treatment Pipeline for Primary Biliary Cholangitis: Sorting Out the PPARs
MinuteCE®
The Treatment Pipeline for Primary Biliary Cholangitis: Sorting Out the PPARs
Atoosa Rabiee, MD; Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
- Atoosa Rabiee, MD
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
MinuteCE®
The Itch Is More Than Skin Deep: What the Changing Landscape of Primary Biliary Cholangitis (PBC) Means for Your Patients and You
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG; Marlyn Mayo, MD
1.00 credit 10 episodes
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
- Marlyn Mayo, MD
- Atoosa Rabiee, MD
1.00 credit 10 episodes
Treatment for Primary Biliary Cholangitis: Who's on First, Who's on Second?
Treatment for Primary Biliary Cholangitis: Who's on First, Who's on Second?
MinuteCE®
Treatment for Primary Biliary Cholangitis: Who's on First, Who's on Second?
Atoosa Rabiee, MD; Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
- Atoosa Rabiee, MD
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
Goals of Treatment for Primary Biliary Cholangitis: A Balancing Act
Goals of Treatment for Primary Biliary Cholangitis: A Balancing Act
MinuteCE®
Goals of Treatment for Primary Biliary Cholangitis: A Balancing Act
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
1.00 program credit
Your Patient's PBC Treatment: Long-Term Monitoring and Management
Your Patient's PBC Treatment: Long-Term Monitoring and Management
MinuteCE®
Your Patient's PBC Treatment: Long-Term Monitoring and Management
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG; Marlyn Mayo, MD
1.00 program credit
- Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
- Marlyn Mayo, MD
1.00 program credit

2/4